Skip to main content
Equibles

Eversept Partners, LP

Position in ALEC — Alector, Inc.

CIK 1697013 NEW YORK, NY
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,861,984
-$42,893 QoQ
Shares Held
1,423,873
+5.4% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#21
of 140 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. ALEC ranks #43 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 913,880 $121,783,648
2 VERA
Vera Therapeutics, Inc.
 2,212,770 $94,949,960
3 CLDX
Celldex Therapeutics, Inc.
 1,785,941 $66,454,864
4 SNDX
Syndax Pharmaceuticals Inc
 2,798,210 $61,168,870
5 IONS
Ionis Pharmaceuticals Inc
 664,684 $52,702,794
6 TVTX
Travere Therapeutics, Inc.
 798,973 $45,389,656
7 PCVX
Vaxcyte, Inc.
 629,952 $36,619,109
8 GERN
Geron Corp
 18,717,422 $23,958,300

All Filings in ALEC

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,861,984 1,423,873
2026-03-31 $2,904,877 1,351,106
2025-12-31 $1,569,614 1,006,163
2025-09-30 $4,406,626 1,488,725
2025-06-30 $2,780,500 1,986,072
2025-03-31 $759,424 617,418
2024-12-31 $378,179 200,095
2024-09-30 $1,550,642 332,756
2024-06-30 $2,459,495 541,739
2024-03-31 $3,227,749 536,171